Chemed Corporation
CHE · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $7,960 | $8,800 | $7,620 | $8,291 |
| - Cash | $178 | $264 | $74 | $33 |
| + Debt | $141 | $155 | $247 | $324 |
| Enterprise Value | $7,922 | $8,692 | $7,793 | $8,581 |
| Revenue | $2,431 | $2,264 | $2,135 | $2,139 |
| % Growth | 7.4% | 6.1% | -0.2% | – |
| Gross Profit | $854 | $799 | $765 | $770 |
| % Margin | 35.1% | 35.3% | 35.8% | 36% |
| EBITDA | $464 | $414 | $393 | $411 |
| % Margin | 19.1% | 18.3% | 18.4% | 19.2% |
| Net Income | $302 | $273 | $250 | $269 |
| % Margin | 12.4% | 12% | 11.7% | 12.6% |
| EPS Diluted | 19.89 | 17.93 | 16.53 | 16.85 |
| % Growth | 10.9% | 8.5% | -1.9% | – |
| Operating Cash Flow | $417 | $330 | $310 | $309 |
| Capital Expenditures | -$50 | -$57 | -$57 | -$59 |
| Free Cash Flow | $368 | $273 | $253 | $250 |